Related Experiment Video
Updated: May 27, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Percutaneous treatment in acute coronary syndromes
Eduardo Alegría-Barrero1, Raul Moreno
1Eduardo Alegría-Barrero, Interventional Cardiology, Royal Brompton Hospital, London, SW3 6NP, United Kingdom.
Insights
Acute coronary syndromes (ACS) involve blocked coronary arteries. Treatments like drug-eluting stents and new antiplatelet agents improve outcomes by reducing restenosis and cardiac events.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Acute coronary syndromes (ACS), including ST-segment elevation myocardial infarction, stem from acute thrombotic lesions obstructing coronary blood flow.
- Percutaneous coronary interventions aim to restore blood flow and improve clinical outcomes in ACS patients.
Purpose of the Study:
- To review current treatment strategies for ACS.
- To discuss recent advancements in percutaneous coronary interventions and medical therapies for ACS.
Main Methods:
- Review of recent randomized clinical trials.
- Analysis of advances in medical treatment, including novel antiplatelet agents.
- Examination of updated clinical guideline recommendations for ACS management.
Main Results:
- Bare metal stents reduced restenosis and cardiac events compared to balloon angioplasty alone.
- Drug-eluting stents further decreased restenosis rates and clinical events.
- New antiplatelet agents and updated guidelines offer improved therapeutic options.
Conclusions:
- Percutaneous treatment, particularly with drug-eluting stents, has significantly improved ACS outcomes.
- Ongoing research and evolving medical treatments, including new antiplatelet therapies, continue to refine ACS management.
- Adherence to recent guideline recommendations is crucial for optimal patient care in ACS.
Abstract:
Both ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndromes (ACS) are the result of an acute thrombotic lesion obstructing blood flow in the coronary vasculature. Percutaneous treatment has shown to improve clinical outcome in this clinical setting by resolving coronary obstruction with different devices directed to restore coronary blood flow. In comparison with balloon alone angioplasty, implantation of bare metal stents reduced the rate of restenosis and cardiac events, but high rates of restenosis remained, leading to further investigations to develop drug-eluting stents with different pharmacological coatings that reduced restenosis rates and clinical events. In this review, we discuss the current treatment of ACS, reviewing recent randomized clinical trials and advances in medical treatment, including new antiplatelet agents and recent guideline recommendations.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Angina IV: Management
Acute Coronary Syndrome III: Diagnostic Studies